195 related articles for article (PubMed ID: 24083795)
1. Attitudes and approaches to vaginal atrophy in postmenopausal women: a focus group qualitative study.
Utian WH; Maamari R
Climacteric; 2014 Feb; 17(1):29-36. PubMed ID: 24083795
[TBL] [Abstract][Full Text] [Related]
2. Vaginal Health: Insights, Views & Attitudes (VIVA) - results from an international survey.
Nappi RE; Kokot-Kierepa M
Climacteric; 2012 Feb; 15(1):36-44. PubMed ID: 22168244
[TBL] [Abstract][Full Text] [Related]
3. Vulvar and vaginal atrophy in postmenopausal women: findings from the REVIVE (REal Women's VIews of Treatment Options for Menopausal Vaginal ChangEs) survey.
Kingsberg SA; Wysocki S; Magnus L; Krychman ML
J Sex Med; 2013 Jul; 10(7):1790-9. PubMed ID: 23679050
[TBL] [Abstract][Full Text] [Related]
4. The Women's EMPOWER Survey: Women's Knowledge and Awareness of Treatment Options for Vulvar and Vaginal Atrophy Remains Inadequate.
Krychman M; Graham S; Bernick B; Mirkin S; Kingsberg SA
J Sex Med; 2017 Mar; 14(3):425-433. PubMed ID: 28202319
[TBL] [Abstract][Full Text] [Related]
5. Women's voices in the menopause: results from an international survey on vaginal atrophy.
Nappi RE; Kokot-Kierepa M
Maturitas; 2010 Nov; 67(3):233-8. PubMed ID: 20828948
[TBL] [Abstract][Full Text] [Related]
6. Vaginal Health: Insights, Views & Attitudes (VIVA-LATAM): results from a survey in Latin America.
Nappi RE; de Melo NR; Martino M; Celis-González C; Villaseca P; Röhrich S; Palacios S
Climacteric; 2018 Aug; 21(4):397-403. PubMed ID: 29741110
[TBL] [Abstract][Full Text] [Related]
7. Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society.
Menopause; 2013 Sep; 20(9):888-902; quiz 903-4. PubMed ID: 23985562
[TBL] [Abstract][Full Text] [Related]
8. Vaginal health in the United States: results from the Vaginal Health: Insights, Views & Attitudes survey.
Simon JA; Kokot-Kierepa M; Goldstein J; Nappi RE
Menopause; 2013 Oct; 20(10):1043-8. PubMed ID: 23571518
[TBL] [Abstract][Full Text] [Related]
9. Recommendations for the management of postmenopausal vaginal atrophy.
Sturdee DW; Panay N;
Climacteric; 2010 Dec; 13(6):509-22. PubMed ID: 20883118
[TBL] [Abstract][Full Text] [Related]
10. Symptoms, attitudes and treatment perceptions of vulvo-vaginal atrophy in UK postmenopausal women: Results from the REVIVE-EU study.
Domoney C; Short H; Particco M; Panay N
Post Reprod Health; 2020 Jun; 26(2):101-109. PubMed ID: 32627698
[TBL] [Abstract][Full Text] [Related]
11. [Local estrogen therapy--clinical implications--2012 update].
Kokot-Kierepa M; Bartuzi A; Kulik-Rechberger B; Rechberger T
Ginekol Pol; 2012 Oct; 83(10):772-7. PubMed ID: 23383564
[TBL] [Abstract][Full Text] [Related]
12. Vaginal Health: Insights, Views & Attitudes survey in Latin America (VIVA-LATAM): focus on Brazil.
Pompei LM; Wender MCO; de Melo NR; Kulak J; Pardini D; Machado RB; Fernandes CE; Palacios S; Nappi RE
Climacteric; 2021 Apr; 24(2):157-163. PubMed ID: 32869682
[TBL] [Abstract][Full Text] [Related]
13. The CLOSER (CLarifying Vaginal Atrophy's Impact On SEx and Relationships) survey: implications of vaginal discomfort in postmenopausal women and in male partners.
Nappi RE; Kingsberg S; Maamari R; Simon J
J Sex Med; 2013 Sep; 10(9):2232-41. PubMed ID: 23809691
[TBL] [Abstract][Full Text] [Related]
14. What's new in the world of postmenopausal sex?
Iglesia CB
Curr Opin Obstet Gynecol; 2016 Oct; 28(5):449-54. PubMed ID: 27517339
[TBL] [Abstract][Full Text] [Related]
15. The REVIVE (REal Women's VIews of Treatment Options for Menopausal Vaginal ChangEs) survey in Europe: Country-specific comparisons of postmenopausal women's perceptions, experiences and needs.
Nappi RE; Palacios S; Particco M; Panay N
Maturitas; 2016 Sep; 91():81-90. PubMed ID: 27451325
[TBL] [Abstract][Full Text] [Related]
16. The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society.
North American Menopause Society
Menopause; 2007; 14(3 Pt 1):355-69; quiz 370-1. PubMed ID: 17438512
[TBL] [Abstract][Full Text] [Related]
17. Women's preferences toward attributes of local estrogen therapy for the treatment of vaginal atrophy.
Mattsson LÅ; Ericsson Å; Bøgelund M; Maamari R
Maturitas; 2013 Mar; 74(3):259-63. PubMed ID: 23312488
[TBL] [Abstract][Full Text] [Related]
18. Attitudes and perceptions towards vulvar and vaginal atrophy in Italian post-menopausal women: Evidence from the European REVIVE survey.
Nappi RE; Particco M; Biglia N; Cagnacci A; Di Carlo C; Luisi S; Paoletti AM
Maturitas; 2016 Sep; 91():74-80. PubMed ID: 27451324
[TBL] [Abstract][Full Text] [Related]
19. Position of the Spanish Menopause Society regarding vaginal health care in postmenopausal women.
Sánchez-Borrego R; Manubens M; Navarro MC; Cancelo MJ; Beltrán E; Duran M; Orte T; Baquedano L; Palacios S; Mendoza N;
Maturitas; 2014 Jun; 78(2):146-50. PubMed ID: 24720907
[TBL] [Abstract][Full Text] [Related]
20. Medical and patient attitude towards vaginal atrophy: the AGATA study.
Palma F; Della Vecchia E; Cagnacci A;
Climacteric; 2016 Dec; 19(6):553-557. PubMed ID: 27736240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
